Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Sodium Chloride 0.9%, Dexamethasone, Chloroprocaine Injection [Clorotekal].
- Кому может быть актуально
- Состояния в реестре: Knee Arthroscopy. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Франция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy: a Double-blind, Randomized, Controlled Trial
Обзор
Chloroprocaine is a short-acting local anesthetic that allows rapid recovery and early ambulation but is currently recommended for procedures lasting 40 minutes or less. Dexamethasone is commonly used during anesthesia for the prevention of postoperative nausea and vomiting and has also been shown to prolong the duration of analgesia and sensory block after regional anesthesia. Dexamethasone may therefore extend the duration of chloroprocaine spinal anesthesia, potentially allowing its use for longer surgical procedures while maintaining the benefits of rapid postoperative recovery. This study aims to evaluate whether intravenous dexamethasone can prolong the effects of spinal anesthesia performed with chloroprocaine in adults undergoing knee arthroscopy.
Подробное описание
This is a monocenter, prospective, randomized (1:1 ratio), controlled, parallel-group, double-blind, phase III superiority trial assessing the efficacy and the safety of IV dexamethasone for prolonging sensory block in patients undergoing knee arthroscopy under spinal anesthesia with chloroprocaine.
Participants will be randomly allocated into two groups:
* Group CHLORO (control group): Patients will receive spinal anesthesia with chloroprocaine 40mg (Clorotekal®10 mg/mL, solution for injection, 4 mL) combined with an IV infusion of 3 mL of normal saline solution diluted in 100 mL of 0.9% sodium chloride, administered over 20 minutes. * Group CHLORODEX (experimental group): Patients will receive spinal anesthesia with chloroprocaine 40 mg (Clorotekal®10 mg/mL, solution for injection, 4 mL) combined with an IV infusion of dexamethasone at a dose of 0.15 mg/Kg (maximum 16 mg), diluted in 100 mL of 0.9% sodium chloride, administered over 20 minutes.
To ensure blinding, study infusions (saline or dexamethasone) will be prepared in identical 100 mL bags and labelled by a pharmacy staff member or an "outside protocol" healthcare professional (physician or nurse) not involved in patient care or assessment.
The infusion will start approximately 10-15 minutes before the spinal punction.
In the operating room, patients will receive standard perioperative care for spinal anesthesia, including placement of a peripheral intravenous line, supplemental low-flow oxygen therapy to maintain SpO₂ \> 93%, continuous hemodynamic monitoring, and strict aseptic precautions. Analgesic premedication with paracetamol combined with either ketoprofen or celecoxib will be administered according to institutional practice.
Spinal anesthesia will be performed with the patient in a semi-sitting position via the L3-L4 or L4-L5 interspace using a 25G x 80mm Sprotte needle. After cerebrospinal fluid reflux, 40 mg of chloroprocaine without adjuvant will be injected intrathecally, and patients will then be positioned in the supine position for the procedure.
Knee arthroscopy will be performed according to standard surgical practice, without any modification of the surgical procedure for study purposes.
No additional sedation or analgesia will be administered during the procedure. In the event of failure of spinal anesthesia or early recovery of sensation, conversion to general anesthesia or deep sedation may be performed at the discretion of the anesthesiologist, depending on the clinical situation.
Postoperatively, multimodal analgesia will be initiated according to the institutional protocol, combining paracetamol, nefopam, and either ketoprofen or celecoxib, with morphine administered if necessary.
Sensory and motor blocks will be assessed every 5 minutes after spinal puncture until regression of two dermatomes and then every 10 minutes until recovery of four dermatomes and complete motor function (maximum until hospital discharge).
Motor block will be assessed using the Bromage score and sensory block will be assessed using the Pin Prick test and the cold test.
The primary objective of the study is to evaluate the efficacy of intravenous dexamethasone in prolonging sensory block following spinal anesthesia with chloroprocaine, as assessed by the time from intrathecal injection to regression of sensory block by two dermatomes from the highest level of sensory block achieved, as measured by the pin-prick test.
Вмешательства
- Препарат Sodium Chloride 0.9%
IV infusion of 3 mL of normal saline solution diluted in 100 mL of 0.9% sodium chloride, administered over 20 minutes - Препарат Dexamethasone
IV infusion of dexamethasone at a dose of 0.15 mg/kg (maximum 16 mg), diluted in 100 mL of 0.9% sodium chloride, administered over 20 minutes - Препарат Chloroprocaine Injection [Clorotekal]
Spinal anesthesia with chloroprocaine 40 mg
Первичные конечные точки
- Time to regression of sensory block by two dermatomes (pin-prick test) [Срок оценки: Up to 2 hours following spinal anesthesia]
Вторичные конечные точки (12)
- Time to complete resolution of motor block [Срок оценки: Up to 8 hours following spinal anesthesia]
- Time to regression of sensory block by four dermatomes (pin-prick test) [Срок оценки: Up to 8 hours following spinal anesthesia]
- Maximum sensory block level [Срок оценки: Up to 30 minutes following spinal anesthesia]
- Time to maximum sensory block level [Срок оценки: Up to 30 minutes following spinal anesthesia]
- Need for additional anesthetic procedure [Срок оценки: From spinal anesthesia to the end of surgery]
- Time to regression of sensory block by two dermatomes (cold test) [Срок оценки: Up to 2 hours following spinal anesthesia]
- Incidence of hypotension [Срок оценки: From spinal anesthesia to 24 hours after surgery]
- Incidence of bradycardia [Срок оценки: From spinal anesthesia to 24 hours after surgery]
- Incidence of nausea [Срок оценки: From spinal anesthesia to 24 hours after surgery]
- Incidence of vomiting [Срок оценки: From spinal anesthesia to 24 hours after surgery]
- Incidence of pruritus [Срок оценки: From spinal anesthesia to 24 hours after surgery]
- Incidence of urinary retention [Срок оценки: From spinal anesthesia to 24 hours after surgery]
Критерии участия
Критерии включения
- Undergoing knee arthroscopy lasting ≤ 40 minutes requiring spinal anesthesia (diagnostic arthroscopy or meniscal surgery),
- Signed written informed consent form,
- Affiliation to a social security system,
- Negative pregnancy test on the day of procedure for non-menopausal patients.
Критерии исключения
- Contraindications to spinal anesthesia with intrathecal chloroprocaine
- History of diabetes,
- Pre-existing peripheral neuropathy,
- American Society of Anesthesiologists (ASA) physical status IV,
- Contraindication to dexamethasone,
- Hypersensitivity of any drug used in this study,
- Long-term oral corticosteroid therapy,
- Chronic opioid use,
- Chronic pain syndromes,
- Contraindications to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (Ketoprofen, Celecoxib)
- Need for a peripheral nerve block in addition to spinal anesthesia (e.g. knee ligamentoplasty),
- Mental or linguistic inability to understand the study,
- Patients under legal protection (guardianship, curatorship or safeguard of justice),
- Patients currently included or planning to be included in another interventional study,
- Pregnant or breastfeeding women,
- Women of childbearing potential not using effective contraception.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Четверное слепое
- Основная цель
- Лечение
Центры проведения
Франция · 1 центр
- Clinique Drouot Rémusat — Paris
Идентификаторы
NCT: NCT07674576 · 2023/01 · 2023-505247-39-00